Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial

NCT06957093 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus Type 2 (T2DM)
Artificial Intelligence (AI)

Interventions

OTHER: artificial intelligence
OTHER: Routine diagnosis and treatment group for diabetes

Sponsor

The First Hospital of Jilin University